Navigation Links
InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
Date:7/31/2008

e its goal of having no more than 5% of

patients lost to follow-up at the time of the week 72

assessment.

ITMN-191:

-- On April 2, InterMune reported top-line results in the four dose

cohorts of treatment-naive patients chronically infected with

hepatitis C virus (HCV) genotype 1 in its Phase 1b multiple-

ascending-dose (MAD) monotherapy trial of ITMN-191:

-- Day 14 median viral kinetic results competitive with those

published for other direct antiviral compounds when used in

monotherapy for 14 days. Specifically, InterMune reported a

median 3.8 log reduction (equal to 99.98% reduction) in HCV RNA

from baseline at Day 14;

-- Significant and rapid viral kinetic activity when dosed every

12 hours; and

-- Excellent safety and tolerability in all dosage regimens.

-- InterMune reported successful completion of 13-week toxicology

studies in rats and monkeys at exposures higher than those expected

to be evaluated in clinical studies. These preclinical studies were

required before initiating the Phase 2 program of ITMN-191 which

will involve durations of therapy longer than those studied in Phase

1.

-- Announced on May 29 the initiation of a 14-day study of ITMN-191 in

combination with Pegasys(R) (pegylated interferon alpha-2a) and

Copegus(R) (ribavirin). The study is proceeding as planned.

-- Submitted several abstracts for possible presentation at the 59th

Annual Meeting of the American Association for the Study of Liver

Diseases (AASLD) to be held October 31 - November 4, 2008 in San

Francisco, including but not limited to data on ITMN-191.

Financial:

-- On June 24, InterMune exchanged $85 million
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)...  Health Enhancement Products, Inc. (OTCQB: HEPI), a ... and metabolic processes, is pleased to announce the addition of ... Nola E. Masterson , a California ... September 17, 2014. "We,re very pleased and ... states Andrew Dahl , President and CEO. "She joins ...
(Date:9/18/2014)... Washington, D.C. (PRWEB) September 18, 2014 ... Dick Durbin and Sen. Jim Risch for National Lab ... research projects from across the national laboratory system. Durbin ... Caucus, which aims to increase awareness of the reach ... breakthrough technologies and discoveries to address some of our ...
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global Human Albumin Industry Report 2014" ... Human Albumin Industry Report 2014 is a professional and ... human albumin industry. The report provides a ... and industry chain structure. The human albumin market analysis ...
(Date:9/18/2014)...  U.S. biotech company Kultevat has strengthened ... technology developed by the Donald Danforth Plant Science ... for applications in production of natural rubber in ... developed under the direction of Roger Beachy , ... of the Danforth Plant Science Center, and is used ...
Breaking Biology Technology:Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 3Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Kultevat obtains license of gene switch technology 2
... second time this year, a tech-based company in Wisconsin has ... public. Called an initial public offering, this kind of business ... who are directly involved, but to others who may follow ... company, has filed papers with the Securities and Exchange ...
... Madison, Wis. - Alfalight , a manufacturer ... and development contract worth $1.7 million from the ... Alfalight will develop pump modules suitable for pumping high-power, ... for defense applications and new commercial products. , ,Manoj ...
... athlete only three years ago, but his Milwaukee-based mobile software ... opening in 1996. , ,And now, the route of ... Asia. , ,Psuik, founder and owner of Developer ... with O2 , a European mobile phone provider, to ...
Cached Biology Technology:Wisconsin IPOs are a harbinger of growing tech economy 2Wisconsin IPOs are a harbinger of growing tech economy 3Milwaukee software developer gains bottom line, loses waistline 2Milwaukee software developer gains bottom line, loses waistline 3Milwaukee software developer gains bottom line, loses waistline 4
(Date:9/18/2014)... cheerful, happy-go-lucky characters, so you might expect that most ... In fact some dogs are distinctly more pessimistic than ... , "This research is exciting because it measures positive ... It offers researchers and dog owners an insight into ... Dr Melissa Starling, from the Faculty of Veterinary Science. ...
(Date:9/18/2014)... 18, 2014 Elsevier, a world-leading provider of ... and the Australasian Research Management Society (ARMS), recognized ... at the 5th Scopus Young Researcher of the ... today at the National Convention Centre and in ... attended by guests representing Australia,s and New Zealand,s ...
(Date:9/18/2014)... swim up to 400 kilometres in search of a home, ... , Clownfish spend their entire adult lives under the protection ... the open ocean, says study co-author, Dr Hugo Harrison from ... CoE) at James Cook University. , "In the past we ... a rare glimpse into how far they can swim, crossing ...
Breaking Biology News(10 mins):Dogs can be pessimists too 2Dogs can be pessimists too 3Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Nemo's epic journey to find a new home 2
... RESTON, Virginia, February 10 WCC Smart Search ... match software, today,announced its participation as a subcontractor ... - Unrestricted (BOSS-U) program. , ... will compete for,task orders with an overall ceiling ...
... The National Science Foundation has awarded a five-year, ... and two other universities to fund a research ... new technologies include improved monitoring of large-scale water ... of detecting dangerous chemical or biological contaminants. ...
... squeezing the middle class on land, it,s also affecting ... Conservation Society (WCS) and other organizations, researchers discovered a ... and low fish levels. Curiously, areas with both ... levels. Appearing in the latest edition of ...
Cached Biology News:WCC Smart Search & Match to Support U.S. Army's BOSS-U Program 2NSF to fund water and environment technology center 2Study says 'middle class' coral reef fish feel the economic squeeze 2
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
... The E. coli protein sample ... to give a consistent pattern when ... rehydration and sample buffer. This sample ... to validate your 2-D system and ...
... Tecans new HydroFlex platform provides ... a range of 96-well format applications, ... and protein arrays, and vacuum filtration-to-waste, ... platforms outstanding on-line control features set ...
Biology Products: